[{"NetIncomeLoss_2_Q2_USD":-15915000.0,"OtherAssetsNoncurrent_0_Q2_USD":2549000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":6593000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":2421000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":20000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":8000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":4119000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":1743000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":1056624.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":1082932.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":4431000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.699,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":17000.0,"IncomeTaxesPaid_2_Q2_USD":39000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.011,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":2476000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":169000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":82000.0,"AssetsCurrent_0_Q2_USD":82635000.0,"OperatingLeaseExpense_2_Q2_USD":50000.0,"OperatingLeaseExpense_1_Q2_USD":20000.0,"AccruedVacationCurrent_0_Q2_USD":353000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":33701000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q2_pure":0.01,"TemporaryEquitySharesOutstanding_0_Q2_shares":21435632.0,"TemporaryEquityParOrStatedValuePerShare_0_Q2_USD":0.0001,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-8798000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-293000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":11871000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":7099000.0,"InvestmentsAndCash_0_Q2_USD":77142000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":36177000.0,"TemporaryEquityLiquidationPreference_0_Q2_USD":165500000.0,"TemporaryEquitySharesAuthorized_0_Q2_shares":180059639.0,"AccruedBonusesCurrent_0_Q2_USD":534000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":286000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-94000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-46000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q2_pure":0.677,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2_Q2_USD":400000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1_Q2_USD":200000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":4000.0,"TemporaryEquitySharesIssued_0_Q2_shares":21435632.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-902000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":81100000.0,"OtherAssetsCurrent_0_Q2_USD":904000.0,"DeferredCostsCurrentAndNoncurrent_0_Q2_USD":1400000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-15895000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":585000.0,"ShortTermInvestments_0_Q2_USD":74516000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":162612000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":24606693.0,"ProfitLoss_2_Q2_USD":-15915000.0,"StockholdersEquity_0_Q2_USD":-83819000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":77125000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-86257000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-12673000.0,"CommonStockSharesOutstanding_0_Q2_shares":1087059.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":17000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":434000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-14247000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":77142000.0,"LiabilitiesCurrent_0_Q2_USD":6395000.0,"AccountsPayableCurrent_0_Q2_USD":1964000.0,"NonoperatingIncomeExpense_2_Q2_USD":75000.0,"NonoperatingIncomeExpense_1_Q2_USD":36000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":1526000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.677,"ProceedsFromStockOptionsExercised_2_Q2_USD":107000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":180000.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":2626000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":6593000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.006,"PropertyPlantAndEquipmentNet_0_Q2_USD":4000.0,"NetIncomeLoss_1_Q2_USD":-8806000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-8.13,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":24606693.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-15.06,"OperatingExpenses_2_Q2_USD":15990000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":107000.0,"CommonStockSharesIssued_0_Q2_shares":1087059.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":77142000.0,"Assets_0_Q2_USD":85188000.0,"ShareBasedCompensation_2_Q2_USD":753000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":24786667.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":2.82,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":4.21,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":345000.0,"CommonStockSharesAuthorized_0_Q2_shares":228300000.0,"OperatingIncomeLoss_2_Q2_USD":-15990000.0,"OperatingIncomeLoss_1_Q2_USD":-8842000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":300000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q2_USD":300000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":85188000.0,"DividendsPayableCurrentAndNoncurrent_0_Q2_USD":0.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":753000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":434000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":5500000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":92000.0,"OperatingExpenses_1_Q2_USD":8842000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":218000.0,"Ticker":"IMGO","CIK":"1623715","name":"IMAGO BIOSCIENCES, INC.","OfficialName":"Imago BioSciences Inc. Common stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"606719826.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210819"}]